U.S. Enteral Nutrition Products Market Size, Share & Industry Analysis, By Product Type (Oral Feeding Products and Tube Feeding Products), By Form (Powder and Liquid), By Age Group (Pediatrics and Adults), By Indication (Oncology, Gastrointestinal Disorder, Neurology, and Others), By End User (Hospitals, Specialty Clinics, Long-term Care Centers, Homecare Settings, and Others), and Country Forecast, 2024-2032

The U.S. enteral nutrition products market size was valued at USD 2.84 billion in 2023. The market is projected to grow from USD 2.98 billion in 2024 to USD 4.86 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period.

Enteral nutrition refers to administering support to patients whose nutritional requirements are not met by the provision of a normal diet. It can include delivering food through oral feeding or tube feeding to patients. These products are used for patients suffering from various chronic disorders, including cancer, gastrointestinal disorders, and neurological disorders, among others.

The rising prevalence of these chronic diseases is resulting in the rising number of patient admissions in the U.S., further increasing the number of cases of enteral feeding in the country. These factors are likely to contribute to the growing demand for these products.

• For instance, according to a 2023 study conducted by the Crohn’s & Colitis Foundation, nearly 1 in 100 people have some form of Inflammatory Bowel Disease (IBD) in the U.S.

Additionally, the growing focus on advanced products, such as blenderized enteral products, disease-specific products, and others among the key players to cater to the rising demand is likely to contribute to the growing U.S. enteral nutrition products market share.

The market exhibited slower growth during the COVID-19 pandemic owing to limited availability of these products, delays & interruptions in enteral feeding, and other factors.  This, along with disruptions in the delivery of nutritional products among manufacturers, limited the adoption of these products among patients during this period.

U.S. Enteral Nutrition Products Market Trends

Patients’ Shifting Preference Toward Disease-Specific Products

There is a rising focus on the delivery of adequate nutrition among healthcare professionals to cater to the growing demand among patients. The factors boosting the demand for adequate nutrition among patients are the increasing prevalence of chronic disorders, such as cancer, neurological disorders, and others and advancements in enteral nutrition products.

Enteral nutrition provides critical macro and micronutrients to individuals finding it difficult to take their foods orally to meet their nutritional needs. This form of nutrition is required for many conditions among patients, such as diabetes, neurological disorders, and cardiovascular disorders, among others.

Additionally, every patient has a specific requirement for nutrient intake according to their medical condition. For instance, a diabetic patient needs to take insulin regularly. The role of enteral nutrition in patients with diabetes is to provide specific nutrients, including vitamins, minerals, energy, among others, to reduce the risk of malnutrition.

A patient suffering from metabolically adapted cancer may require enteral feeding with a formula high in fats, proteins, and EPA + DHA. Consuming disease-specific nutrition products improves functional requirements and nutrition level among patients. Moreover, there has been an increasing focus among researchers on conducting a higher number of clinical studies concerning these specific nutrition formulas to meet the nutritional requirements of patients.

The prominent players operating in the market are also focusing on research and development activities to develop disease-specific enteral nutrition products in the country.

• For instance, in April 2022, Abbott announced the release of metabolic nutrition formulas, including its specialty product Similac PM 60/40, at the request of the U.S. FDA. Similac PM 60/40 is a low-iron infant formula used to feed infants with or at a risk of hypocalcemia due to hyperphosphatemia, or with renal impairment who would benefit from low-mineral food.

U.S. Enteral Nutrition Products Market Growth Factors

Increasing Prevalence of Chronic Conditions Among Citizens to Fuel Product Demand

The prevalence of chronic conditions, such as cancer, various neurological disorders, such as Alzheimer’s disease, among others, is growing in the U.S. This factor is increasing the need for these products among individuals who are unable to maintain adequate nutritional intake owing to temporary or permanent dysfunction in their swallowing mechanism, physiological symptoms related to their diseases, such as nausea, poor appetite, or taste changes.

• According to a 2023 report published by the Alzheimer's Association, more than 6 million Americans are living with Alzheimer’s Disease.

The rising geriatric population is also a contributing factor to the growing prevalence of chronic conditions among patients. This segment of the population is more prone to various chronic disorders owing to existing underlying conditions, comparatively lower immune health, and other factors.

• According to the 2023 statistics published by the Administration for Community Living (ACL), people aged 65 years and above in the U.S. represented around 17.3% of the total population in the country in 2022. This proportion is projected to grow to 22% by 2040.


• According to a 2024 article by the National Council on Aging (NCOA), approximately 94.9% of adults aged 60 and above have at least one chronic condition, and 78.7% have two or more.

These factors, along with rising awareness about the benefits of enteral nutrition products, are expected to spur their demand, thereby supporting the U.S. enteral nutrition products market growth during the forecast period.

RESTRAINING FACTORS

Limited Reimbursement for Medical Nutrition Technologies to Limit Market Growth

The coverage policy for medical foods or Foods for Special Medical Purposes (FSMPs) varies by country and healthcare settings. According to a 2019 study published by ScienceDirect, the reimbursement of medical foods in countries, such as France, Germany, Spain, and the Netherlands is higher across all healthcare settings, such as hospitals, outpatient settings, and community care centers. However, the reimbursement in the U.S. for these products is limited across healthcare settings.

• According to a 2023 article published by the Centers for Medicare & Medicaid Services (CMS), enteral nutrition is covered under the Prosthetic Device benefit. Enteral nutrition for temporary impairments, orally administered enteral nutrition products, related supplies, and equipment will be denied as non-covered, no benefit.

Furthermore, several countries follow the formal Health Technology Assessment (HTA) for medical nutrition products, including enteral nutrition products. However, there is a lack of HTA in the U.S., due to which the prices of the products are set based on the macronutrients included in the formulation of FSMP/MF and the quantity of specific ingredients rather than the demonstrated health outcomes.

The lack of financial incentives for manufacturers to invest in clinical research for enteral medical nutrition technologies may hamper innovation and the ability of the healthcare ecosystem to promote the role of medical nutrition. Therefore, the aforementioned factors are expected to limit the adoption of these products, thereby hindering the growth of the market.

U.S. Enteral Nutrition Products Market Segmentation Analysis

By Product Type Analysis

Increasing Number of Product Launches Helped Tube Feeding Products Dominate Market

Based on product type, the market is segmented into oral feeding products and tube feeding products.

The tube feeding products segment dominated the market in 2023. These products are considered complete nutrition products as they offer all essential nutrients, such as carbohydrates, proteins, fats, minerals, fiber, vitamins, and water to cater to the nutritional requirements of the patients. This, along with the growing demand for innovative nutritional formulas, including blenderized products and plant-based protein and organic products, is resulting in the increasing focus of key players on launching novel products in the market.

• For instance, in November 2023, Kate Farms, one of the players in plant-based nutrition, launched whole-food pediatric blended meals to provide a convenient way to meet the nutritional requirements of pediatric patients.

The oral feeding products segment is also expected to grow with a considerable growth during the forecast period. The growth is due to certain benefits of these products, such as non-invasive and effective, further supporting their growing demand among patients. This, along with the rising number of inorganic growth strategies, such as acquisitions and mergers among key players to raise awareness about the benefits of these products, is likely to support the growth of the segment in the market.

By Form Analysis

Adoption of Liquid Products Increased Among Patients Due to Their Wide-Ranging Benefits

Based on form, the market is segmented into powder and liquid.

The liquid segment dominated the market in 2023 owing to the rising demand for liquid nutrition formulas among patients, resulting in the growing focus of key players on research and development activities to introduce innovative liquid formulas in the market. This, along with distinct benefits offered by liquid nutrition formulas, such as high remission rates and easy absorption, among others, is likely to contribute to their growing demand.

• According to a 2022 article published by the National Center for Biotechnology Information (NCBI), liquid enteral nutrition formula has proven to increase remission rates and reduce the need for steroids and surgeries among patients.

The powder segment is also expected to grow with a considerable growth during the forecast period. The segment’s growth is due to certain factors, such as high affordability, resulting in the rising demand for these products. Moreover, implementation of strategic initiatives, such as mergers and collaborations among the key players to strengthen their market presence is likely to increase the number of product launches, thereby supporting the growth of the segment.

By Age Group Analysis

Rising Incidence of Chronic Disorders Boosted Product Adoption Among Adults

Based on age group, the market is segmented into pediatrics and adults. The adults segment dominated the market in 2023.

The dominance of the segment is owing to the rising prevalence of chronic disorders, such as cardiovascular diseases, neurological diseases, and others among adults. This has resulted in the growing demand for enteral nutrition products among these patients. This factor, coupled with rising advancements in these nutrition products, is likely to support the growth of the segment.

The pediatrics segment is also expected to grow with a considerable growth during the forecast period. The segment’s growth is due to the benefits of enteral nutrition for pediatric patients, including safety, effectiveness, growth, and recovery, among others. This, along with a rising focus of key players on research and development activities to introduce products with novel ingredients, is likely to support the growth of the segment.

• For instance, according to the 2020 data published by the Abbott Nutrition Health Institute, more than 200,000 children needed home tube feeding in the U.S. Thus, the growing demand for enteral nutrition at home among pediatric patients is likely to support the adoption of these products.

By Indication Analysis

Increasing Prevalence for Gastrointestinal Disorders Boosted Product Demand

The market is segmented into oncology, gastrointestinal disorders, neurology, and others based on indication.

The gastrointestinal disorders segment accounted for the largest U.S. enteral nutrition products market share in 2023. The segment’s growth is due to the growing prevalence of gastrointestinal disorders, such as inflammatory bowel syndrome, resulting in rising patient admissions for the treatment of these disorders. The effects associated with these disorders, such as malnutrition, is fueling the demand for enteral nutrition products. Moreover, growing advancements in these products are further augmenting their adoption among patients, thereby supporting the segment’s dominance.

The oncology segment is also expected to grow with a considerable growth during the forecast period. The segment’s growth is due to the rising prevalence of cancer among patients, accelerating the demand for disease-specific enteral nutrition products. This, along with an increasing number of domestic players offering innovative products for enteral nutrition, is further likely to support the demand for these products.

• For instance, according to a 2023 article published by the American Association for Cancer Research (AACR), approximately 1.96 million new cancer cases are estimated to be recorded in the U.S.

By End User Analysis

Patient Admissions Increased in Hospitals Due to Their Expanding Network

Based on end user, the market is segmented into hospitals, specialty clinics, long-term care centers, homecare settings, and others. The hospitals segment dominated the market in 2023.

The dominance of the segment is owing to the rising number of hospitals, resulting in increased patient admissions for enteral nutrition, supporting the demand for these products. In addition, increasing awareness about novel products, such as blenderized products is further boosting their adoption.

• For instance, according to the data published by ABOVE & BEYOND THERAPY, there are approximately 7,335 hospitals in the U.S. Thus, the increasing number of hospitals is further supporting the growing patient admissions, thus contributing to the high adoption of these products.

The homecare settings segment is expected to grow with a substantial growth during the forecast period. Increasing awareness about the benefits of at-home enteral nutrition among patients, such as length of stay and others and increasing focus on at-home enteral feeding among healthcare providers are some of the factors bolstering the adoption of these products.

KEY INDUSTRY PLAYERS

Robust Focus of Key Players to Strengthen Their Product Portfolio Will Favor Market Growth 

The U.S. market is consolidated, with a few prominent players, such as Abbott, Nestlé, and Nutricia (Danone) operating with a robust product portfolio.

Nestlé dominated the enteral nutrition products market in the U.S. in 2023. The growth is due to the company’s rising focus on R&D activities to develop and introduce innovative nutrition products in the market. The increasing focus of the company on developing personalized nutrition products, acquisitions, and mergers, among others, are some of the other factors contributing to its dominance.

• In January 2024, Nestlé collaborated with Global Shapers, an initiative by the World Economic Forum, and Accenture to support youth innovation to accelerate their breakthrough ideas. This helped the company increase its brand presence in the market.

Additionally, the growing focus of key players, including Abbott, on launching advanced nutrition products is increasing the company’s market share. Similarly, the growing focus of other key players, such as Nutricia (Danone) and B. Braun SE on the inorganic growth strategies to increase their brand presence is likely to support their growth in the market.

LIST OF TOP ENTERAL NUTRITION PRODUCTS COMPANIES IN U.S./ LIST OF TOP ENTERAL NUTRITION PRODUCTS COMPANIES:

• Nutricia (Danone) (Netherlands)


• Abbott (U.S.)


• Nestlé (Switzerland)


• B. Braun SE (Germany)


• Medtrition Inc. (U.S.)


• Reckitt Benckiser Group PLC (U.K.)


• Victus (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• January 2024 – Danone partnered with a digital oncology company, Resilience, to provide better nutritional care for patients with cancer.


• June 2023 – Abbott collaborated with The American Diabetes Association to improve the therapeutic nutrition of patients who have diabetes.


• April 2022 – Abbott announced the release of metabolic nutrition formulas that were previously on hold following its recall of some powder infant formulas in limited quantities. This helped the company strengthen its presence in the U.S.


• February 2022 – Nestlé acquired Orgain, a leader in plant-based nutrition, to strengthen its portfolio of health and wellness products. This helped the company increase its brand presence in the U.S.


• November 2021 – Abbott launched Similac 360 Total Care, an infant formula with five HMO prebiotics, to widen its product portfolio.

REPORT COVERAGE

The report provides a detailed market analysis. It focuses on key aspects, such as market size & forecast and segmentation based on product type, form, age group, indication, end user, and competitive landscape. It also gives an overview of the prevalence of key chronic disorders and provides a pricing analysis of products for significant companies.

Besides, the report offers insights into the latest market trends, statistics, and key industry developments. In addition to the factors mentioned above, it encompasses several factors that have contributed to the market's growth in recent years.

Report Scope & Segmentation

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 6.3% from 2024-2032
Unit	Value (USD billion)
Segmentation	By Product Type Oral Feeding Products By Form By Age Group By Indication By End User Tube Feeding Products By Form By Age Group By Indication By End User
By Form Powder Liquid
By Age Group Pediatrics Adults
By Indication Oncology Gastrointestinal Disorder Neurology Others
By End User Hospitals Specialty Clinics Long-term Care Centers Homecare Settings Others